Pathogens (Basel, Switzerland) · 2026
Genetic Determinants Linked to MDR/XDR in Pseudomonas aeruginosa Strains from a Mexican Tertiary Hospital.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nicolas-Sayago Liliana, Loyola-Cruz Miguel Ángel, Vásquez-Martínez Yesseny, Cortez-San Martín Marcelo, Márquez-Valdelamar Laura Margarita, Cruz-Cruz Clemente, Durán-Manuel Emilio Mariano, Ruíz-Valdés Mireya, Calzada-Mendoza Claudia Camelia, Rojas-Bernabé Araceli, Tamayo-Ordóñez María Concepción, Tamayo-Ordóñez Yahaira de Jesús, Castañeda-Ortega Julio César, López-Martínez Briceida, Hernández-Castellanos Benito, Moreno-Torres Daniela, Castro-Escarpulli Graciela, Bello-López Juan Manuel
Аннотация
BACKGROUND: Pseudomonas aeruginosa is one of the leading agents causing healthcare-associated infections (HAIs) due to its intrinsic resistance, its capacity to acquire resistance mechanisms, and its persistence in hospital environments. In Mexico, it ranks among the most frequently reported pathogens in national surveillance systems. The aim of this study was to characterize antimicrobial resistance profiles and the genetic determinants associated with MDR/XDR phenotypes in P. aeruginosa strains from HAIs at Hospital Juárez de México (HJM).
METHODS: Sixty-three strains from patients with HAIs were analyzed. Identification was confirmed by 16S rRNA gene sequencing. Antimicrobial susceptibility testing followed CLSI guidelines. MDR/XDR phenotypes were classified according to the Latin American consensus for categorizing MDR, XDR, and PDR pathogens. Screening for resistance mechanisms was carried out by PCR for the main β-lactamases circulating at HJM. Finally, mutations in the oprD gene were detected in imipenem-resistant isolates through amino acid sequence alignment.
RESULTS: Resistant phenotypes allowed the identification of MDR and XDR profiles. Only the metallo-β-lactamase blaVIM was detected. Analysis of oprD porin sequences revealed recurrent mutations (S103T, T115K, L170F, G186P, and T189V) associated with imipenem resistance.
CONCLUSIONS: In P. aeruginosa, the presence of blaVIM and structural alterations in OprD confirms the multifactorial nature of carbapenem resistance. These findings underscore the need to strengthen microbiological surveillance programs and antimicrobial stewardship strategies to mitigate the impact and spread of MDR/XDR isolates.
METHODS: Sixty-three strains from patients with HAIs were analyzed. Identification was confirmed by 16S rRNA gene sequencing. Antimicrobial susceptibility testing followed CLSI guidelines. MDR/XDR phenotypes were classified according to the Latin American consensus for categorizing MDR, XDR, and PDR pathogens. Screening for resistance mechanisms was carried out by PCR for the main β-lactamases circulating at HJM. Finally, mutations in the oprD gene were detected in imipenem-resistant isolates through amino acid sequence alignment.
RESULTS: Resistant phenotypes allowed the identification of MDR and XDR profiles. Only the metallo-β-lactamase blaVIM was detected. Analysis of oprD porin sequences revealed recurrent mutations (S103T, T115K, L170F, G186P, and T189V) associated with imipenem resistance.
CONCLUSIONS: In P. aeruginosa, the presence of blaVIM and structural alterations in OprD confirms the multifactorial nature of carbapenem resistance. These findings underscore the need to strengthen microbiological surveillance programs and antimicrobial stewardship strategies to mitigate the impact and spread of MDR/XDR isolates.